MediSieve's preclinical and first-in-human safety study on the Magnetic Blood Filtration gets published in Nature Scientific Reports.

Magnetic Blood Filtration Platform shown to be safe and well tolerated, with no serious adverse events.

Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s System for the Treatment of Acute Hyperinflammation.

Radboud University Medical Center will perform the first trial of the Novel Magnetic Haemoflitration System.

Award winning company MediSieve is set to start their first-in-man clinical trials in the first quarter of 2022.

The expansion enabled MediSieve to have full control over safety and equipment to meet the company's R&D needs

The team focused its activities on investigating how to help treat COVID-19 patients more effectively.

The current pandemic is a stark reminder to us all of the importance of our work and its potential impact.

MediSieve, the company behind a revolutionary magnetic sieve that filters out malaria-infected cells directly from a patient’s bloodstream, is developing new methods to fight leukaemia.